Deadline: July 28, 2025
Are you a researcher or technology transfer office looking to spotlight your groundbreaking life sciences innovation? The BioNTX Tech Transfer Showcase 2025 is your chance to connect with industry leaders, investors, and commercial partners, and take your innovation from concept to market.
Hosted by BioNTX, this annual showcase highlights early-stage academic innovations from across the Southern U.S. and facilitates their transition into commercially viable solutions. If you’re ready to make an impact in health innovation, biotechnology, and medical science, don’t miss this opportunity.
What is the BioNTX Tech Transfer Showcase 2025?
The BioNTX Tech Transfer Showcase 2025 is a premier regional platform designed to:
- Elevate academic research in life sciences
- Support early-stage innovations towards commercialisation
- Foster partnerships between universities, startups, investors, and industry experts
Selected participants will present their technologies to a curated audience during the prestigious iC³ Life Science Summit 2025, held in Dallas, Texas.
Important Dates and Timeline
- Application Deadline: July 28, 2025 (by 5 PM CST)
- Winners Announced: August 7, 2025
- Pitch Deck Draft Deadline: August 18, 2025
- Final Pitch Submission: September 15, 2025
- iC³ Life Science Summit Showcase: September 17, 2025
Why You Should Apply
Participating in the BioNTX Tech Transfer Showcase 2025 comes with multiple benefits:
- Visibility: Showcase your innovation to a broad network of investors, corporate scouts, and life sciences executives.
- Mentorship: Gain feedback and pitch training through BioNTX’s support system.
- Collaboration: Form connections with industry partners and potential licensors.
- Commercial Potential: Position your work for future funding and technology licensing opportunities.
Who is Eligible?
The programme is open to institutions and researchers in the following U.S. states:
- Texas
- Arkansas
- Louisiana
- New Mexico
- Oklahoma
- Tennessee
Submissions should highlight early-stage life science technologies, including but not limited to:
- Therapeutics
- Diagnostics
- Medical Devices
- Digital Health
- Platform Technologies
Applicants must be affiliated with a recognised research institution and have their tech transfer office’s endorsement.
Application Requirements
To ensure a competitive application, the following criteria must be met:
- The innovation must be early-stage and protected by intellectual property (IP)
- A maximum of two submissions is allowed per institution
- Application materials must be non-confidential
- Technology must be endorsed by the applicant’s technology transfer office
The Final Showcase: iC³ Life Science Summit 2025
All selected teams will present at the iC³ Life Science Summit 2025, taking place on September 17 in Dallas, TX. This event is an exceptional opportunity to engage with industry experts, investors, and strategic partners in life sciences.
Proven Success and Testimonials
Participants from previous years have shared the programme’s transformational impact:
- A Rice University PhD alumnus said it helped shape their investor pitch and increase visibility.
- A UT Arlington research team noted how the showcase opened commercial opportunities for their invention.
How to Apply
Ready to make your mark at the BioNTX Tech Transfer Showcase 2025?
Final Thoughts
The BioNTX Tech Transfer Showcase 2025 is more than a presentation opportunity — it’s a launchpad for life science innovations ready for commercialisation. Whether you’re a university researcher, startup founder, or tech transfer professional, this is your chance to spotlight transformative research and connect with the people who can help scale it.
Don’t miss the July 28, 2025 deadline. Apply now and take the next step toward bringing your innovation to life.
For proposal drafting, refining and review, contact grantsdatabase.org
